Comments
Vanta Bioscience Limited has announced that its step-down subsidiary ‘Vayam Research Solutions Limited’ has entered into a non-exclusive CRO Service Agreement with Emcure Pharmaceuticals Limited, Pune, for providing services of bio-analytical and bio-equivalence services to the company for a period of three years from 2019 to 2022. In a listing to the bourses today, the company said the agreement provides for a minimum revenue assurance between ₹7 crore and ₹9 crore for the financial year 2019-20 and ₹20 crore for fiscal 2020-21.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.